Letters calls and emails: CHD will not be beaten by quality

Dear Editor

It comes as no surprise to read that quality targets do not reduce CHD (GP, 26 October).

As usual it has led to the knee jerk reaction that we need to drive cholesterol even lower to achieve improved results.

I take the opposite point of view and I suspect we need to review the role of statins in the prevention of CHD.

I have always tried to individualise treatment and started primary prevention for individual patients with a bad family history many years ago.

I suspect that this will not be the only quality indicator that proves completely useless in the fullness of time - a bit like flu vaccination.

Dr Thomas Cullen Clacton on Sea, Essex.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Just published

GP appointment

General practice delivered 342m appointments in 2022 - and lost nearly 500 GPs

General practice in England delivered around 342m appointments in total in 2022 with...

NHS sign

Local GPs unite to take over two practices run by hospital trust

GPs in Swindon have come together to take over two practices that had spent more...

Talking General Practice logo

Podcast: Why are junior doctors preparing to strike?

Talking General Practice speaks to BMA GP trainee committee chair Dr David Smith...

Money

Practices face losing out on QOF income amid soaring demand

GP practices risk losing out on QOF income this year because sky-high demand for...

Nurse giving older man a COVID-19 vaccine

JCVI recommends targeted COVID-19 vaccination programme in 2023

People at higher risk of severe COVID-19 should be offered a booster vaccination...

Health and social care secretary Steve Barclay leaving number 10 Downing Street

Government sets out plans for 'major conditions' health strategy

The government is to set out a strategy to tackle six 'major' health conditions in...